Abstract

Observations on the Food and Drug Administration advisory panel endovascular aortic repair report of type III endoleaks and the call for increased surveillance

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call